Annette Hilgendorf

Patent Attorney

Dr. rer. nat., Dipl.-Biotech.

Dr. Hilgendorf joined df-mp in 2003 and is a member of the firm’s biotechnology and pharmaceuticals practice groups. She is authorized to represent clients before the German Patent and Trademark Office, the German Federal Patent Court, the European Patent Office as well as the European Intellectual Property Office.

+ 49 89 210 296 0
annette.hilgendorf@df-mp.com

Dr. Hilgendorf joined df-mp in 2003 and is a member of the firm’s biotechnology and pharmaceuticals practice groups. She is authorized to represent clients before the German Patent and Trademark Office, the German Federal Patent Court, the European Patent Office as well as the European Intellectual Property Office.

practice areas.

Dr. Hilgendorf has a scientific background in both chemistry and biotechnology, in particular, in protein biochemistry, immunology, molecular biology and microbiology, as well as process engineering (cell culture techniques, microbial process engineering) and plant biotechnology. Dr. Hilgendorf’s practice focuses on drafting and prosecution of patent applications. She has been involved in opposition proceedings before the European Patent Office and in providing opinions regarding infringement, validity and freedom-to-operate in the field of pharmaceuticals and biotechnology.

  

admissions.

  • German Patent Attorney
  • European Patent Attorney
  • European Trademark Attorney
  • European Design Attorney

references and activities.

  • Author of scientific papers on viral immune evasion mechanisms

curriculum vitae.

Since 2008
Since 2008

Patent attorney at df-mp

2007-2008
2007-2008

Trainee at the German Patent Office (DPMA) and the German Federal Patent Court (BPatG)

2003
2003

Joined df-mp as a patent attorney candidate

1999-2003
1999-2003

Doctorate Degree in Biochemistry (magna cum laude) from the Ludwig-Maximilians-Universität München (dissertation on the modulation of cellular receptors upon viral infection, studies on the regulation of intracellular protein transport, cloning of whole adenovirus genomes in bacterial artificial chromosomes)

1999
1999

Diplôme d'études approfondies (DEA) Biologie Moléculaire et Cellulaire at the Ecole Supérieure de Biotechnologie de Strasbourg - Université Louis Pasteur Strasbourg, France

1996-1999
1996-1999

Degree coursework (three years) in Biotechnology at the European Confederation of the Universities Basel, Freiburg, Karlsruhe and Strasbourg (EUCOR) and Diploma thesis at the University of Michigan, Ann Arbor (U.S.A.) in the field of cloning of adenoviral vectors for gene therapy Diplôme d’Ingénieur en Biotechnologie/Diplom in Biotechnologie (German, French and Swiss university degree)

1994-1996
1994-1996

Degree in Chemistry (Vordiplom Chemie) from the Ruprecht-Karls-Universität Heidelberg

association memberships.

publications.

  • “Two distinct transport motifs in the adenovirus E3/10.4-14.5 proteins act in concert to down-modulate apoptosis receptors and the epidermal growth factor receptor“ A. Hilgendorf, J. Lindberg, Z. Ruszics, S. Höning, A. Elsing, M. Löfqvist, H. Engelmann, H.-G. Burgert (2003) Journal of Biological Chemistry Vol. 278, No. 51, pp. 51872-51884
  • “Immune evasion by adenovirus E3 proteins: Exploitation of intracellular trafficking pathways”. M. Windheim, A. Hilgendorf and H.-G. Burgert (2004) Review in Current Topics in Microbiology and Immunology (CTMI) 273: 30-85.
  • “Subversion of host defense mechanisms by adenoviruses” H.-G. Burgert, Z. Ruzsics, S. Obermeier, A. Hilgendorf, M. Windheim and A. Elsing (2002) Review in Current Topics in Microbiology and Immunology (CTMI) 269: 273-318.